Manufacturing practices are evolving to advance antibody drug conjugates (ADCs) ...
The US FDA has approved Galderma's Nemluvio (nemolizumab), for individuals aged ...
The biopharmaceutical industry faces a future full of risks and rewards. But wha...
WuXi AppTec and WuXi Biologics are looking to sell off sites in the US and Europ...
CLN-619 is a monoclonal antibody commercialized by Cullinan Therapeutics, with a...
AOC-1020 is an antisense rnai oligonucleotide commercialized by Avidity Bioscien...
Iluzanebart is a monoclonal antibody commercialized by Vigil Neuroscience, with ...
INB-400 is a gene-modified cell therapy commercialized by IN8bio, with a leading...
Epinephrine is a small molecule commercialized by Aquestive Therapeutics, with a...
JZP-898 is a fusion protein commercialized by Jazz Pharmaceuticals, with a leadi...
SGT-003 is a gene therapy commercialized by Solid Biosciences, with a leading Ph...
FB-102 is a monoclonal antibody commercialized by Forte Biosciences, with a lead...
TN-401 is a gene therapy commercialized by Tenaya Therapeutics, with a leading P...
CTX-131 is a gene-modified cell therapy commercialized by CRISPR Therapeutics, w...
Carisma, a Philadelphia-based biotech company, is undergoing significant restruc...
BioAge Labs, a recent success in the biotechnology IPO market, has made a surpri...
